Search research articles
Contact Us
Filters
Showing results (81-90 of 144) with videos related to
Page
of 15
Sort By:
Radiology. Imaging Cancer
|
September 12, 2025
High-Resolution Mapping of Tumor and Peritumoral Glutamate and Glutamine in Gliomas Using 7-T MRSI
Gilbert Hangel, Philipp Lazen, Cornelius Cadrien, et al.
Cancers
|
March 13, 2024
A Comparison of 7 Tesla MR Spectroscopic Imaging and 3 Tesla MR Fingerprinting for Tumor Localization in Glioma Patients
Philipp Lazen, Pedro Lima Cardoso, Sukrit Sharma, et al.
Neuro-Oncology
|
September 11, 2015
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma
Julia Furtner, Veronika Schöpf, Katharina Seystahl, et al.
European Radiology
|
May 16, 2018
CT colonography: size reduction of submerged colorectal polyps due to electronic cleansing and CT-window settings
Christian Bräuer, Philippe Lefere, Stefaan Gryspeerdt, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
May 29, 2026
Early radiological response pattern predicts long-term response in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors
Markus Kleinberger, Maximilian J Mair, Julia M Berger, et al.
Neuro-Oncology
|
March 7, 2024
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
Emeline Tabouret, Julia Furtner, Thomas Graillon, et al.
Cancers
|
June 2, 2021
5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers
Arthur Hosmann, Matthias Millesi, Lisa I Wadiura, et al.
Cancers
|
November 27, 2021
Reply to Stummer, W.; Thomas, C. Comment on "Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540"
Arthur Hosmann, Matthias Millesi, Lisa I Wadiura, et al.
Therapeutic Advances in Medical Oncology
|
May 17, 2021
Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab
Elisabeth Sophie Bergen, Amelie Binter, Angelika Martina Starzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2022
Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns
Maximilian J Mair, Annette Leibetseder, Gerwin Heller, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 144) with videos related to
Sort By:
Page
of 15
Radiology. Imaging Cancer
|
September 12, 2025
High-Resolution Mapping of Tumor and Peritumoral Glutamate and Glutamine in Gliomas Using 7-T MRSI
Gilbert Hangel, Philipp Lazen, Cornelius Cadrien, et al.
Cancers
|
March 13, 2024
A Comparison of 7 Tesla MR Spectroscopic Imaging and 3 Tesla MR Fingerprinting for Tumor Localization in Glioma Patients
Philipp Lazen, Pedro Lima Cardoso, Sukrit Sharma, et al.
Neuro-Oncology
|
September 11, 2015
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma
Julia Furtner, Veronika Schöpf, Katharina Seystahl, et al.
European Radiology
|
May 16, 2018
CT colonography: size reduction of submerged colorectal polyps due to electronic cleansing and CT-window settings
Christian Bräuer, Philippe Lefere, Stefaan Gryspeerdt, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
May 29, 2026
Early radiological response pattern predicts long-term response in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors
Markus Kleinberger, Maximilian J Mair, Julia M Berger, et al.
Neuro-Oncology
|
March 7, 2024
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
Emeline Tabouret, Julia Furtner, Thomas Graillon, et al.
Cancers
|
June 2, 2021
5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers
Arthur Hosmann, Matthias Millesi, Lisa I Wadiura, et al.
Cancers
|
November 27, 2021
Reply to Stummer, W.; Thomas, C. Comment on "Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540"
Arthur Hosmann, Matthias Millesi, Lisa I Wadiura, et al.
Therapeutic Advances in Medical Oncology
|
May 17, 2021
Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab
Elisabeth Sophie Bergen, Amelie Binter, Angelika Martina Starzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2022
Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns
Maximilian J Mair, Annette Leibetseder, Gerwin Heller, et al.
Page
of 15